• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

N-Methyl-d-Aspartate Receptor Encephalitis Associated With COVID-19 Infection in a Toddler

Emily

Editor, Senior Moderator
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546658/
Burr T, Barton C, Doll E, Lakhotia A, Sweeney M. N-Methyl-d-Aspartate Receptor Encephalitis Associated With COVID-19 Infection in a Toddler. Pediatr Neurol. 2021;114:75-76. doi:10.1016/j.pediatrneurol.2020.10.002

Introduction

Anti–N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis is characterized by mood and behavior changes, seizures, abnormal movements, autonomic instability, and encephalopathy. It occurs most commonly in young adults. A paraneoplastic association has been made with ovarian teratoma, although this is rare in children.[SUP]1[/SUP] More recently patients with anti-NMDAR encephalitis after viral infections have been reported, including herpes simplex virus (HSV), Japanese encephalitis virus, and now the 2019 novel coronavirus (SARS-CoV-2 or COVID-19).[SUP]2[/SUP][SUP], [/SUP][SUP]3[/SUP][SUP], [/SUP][SUP]4[/SUP][SUP], [/SUP][SUP]5[/SUP] We present the first pediatric patient with COVID-19–associated anti-NMDAR encephalitis.
:
Patient Description

This 23-month-old girl developed fever, fussiness, poor sleep, constipation, and decreased oral intake in July 2020. She was fully vaccinated and did not have a personal or family history of frequent infections...
 
Back
Top Bottom